TGF-β signaling plays an important role in resisting γ-irradiation

You Sun An1, Mi-Ra Kim, Seung-Sook Lee

  • 1Division of Radiation Effects, Korea Institute of Radiation and Medical Sciences, Seoul, Korea.

Experimental Cell Research
|December 25, 2012
PubMed

Insights

Transforming growth factor-β1 (TGF-β1) protects cells from gamma irradiation by reducing DNA damage and apoptosis. This signaling pathway enhances cell survival, clarifying its role in cellular response to radiation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Radiation Biology

Background:

  • Transforming growth factor-β1 (TGF-β1) is a key regulator of cellular processes like differentiation, bone remodeling, and angiogenesis.
  • TGF-β1's role in apoptosis is contradictory, with some studies showing induction and others inhibition, highlighting the need for context-specific investigation.
  • Understanding TGF-β1's influence on cell survival and death is crucial for its role in homeostasis and growth.

Purpose of the Study:

  • To investigate the role of TGF-β1 signaling in the cellular response to gamma irradiation.
  • To resolve discrepancies regarding TGF-β1's effect on apoptosis in the context of radiation exposure.
  • To elucidate the mechanisms by which TGF-β1 influences DNA damage and cell survival post-irradiation.

Main Methods:

  • Utilized mink lung epithelial cell lines (Mv1Lu) and their TGF-β receptor-deficient derivatives (R1B, DR26).
  • Assessed the impact of gamma irradiation on DNA fragmentation, Caspase-3 cleavage, and γ-H2AX foci formation.
  • Investigated the requirement of de novo protein synthesis for TGF-β1's radio-protective effects.

Main Results:

  • Canonical TGF-β1 signaling was found to be important in protecting cells against gamma irradiation.
  • Restoration of TGF-β receptors or introduction of active Smads reduced DNA damage markers (fragmentation, γ-H2AX) and apoptosis (Caspase-3 cleavage) in irradiated cells.
  • De novo protein synthesis was essential for TGF-β1 to confer radio-resistance.

Conclusions:

  • TGF-β1 actively protects cells from gamma irradiation by mitigating DNA damage and suppressing apoptosis.
  • The study clarifies TGF-β1's pro-survival role in response to radiation, enhancing overall cell survival.
  • These findings emphasize the importance of TGF-β1 signaling in cellular radio-resistance and DNA repair mechanisms.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...